From their Aug 1 LANI Phase 2 topline data announcement:
"The Company plans to provide a detailed update on the full efficacy and safety results of the Phase 2 IGLOO trial, the status of the LANI program and its corporate strategy during its fourth quarter and fiscal year-end earnings call in early September."
Monday is mid-September...promises promises.